Whitehawk Therapeutics (WHWK) EBITDA (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported EBITDA of -$22.3 million for Q1 2026, down 130.59% year-over-year from $73.0 million in Q1 2025, and up 4.04% on a QoQ basis from -$23.3 million in Q4 2025.
Whitehawk Therapeutics (WHWK) has 17 years of EBITDA data on file, last reported at -$22.3 million in Q1 2026.
- Quarterly EBITDA fell 130.59% year-over-year to -$22.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$115.8 million (down 519.3% YoY) and the FY2025 annual result came in at -$20.5 million, up 67.83% from the prior year.
- EBITDA advanced to -$22.3 million in Q1 2026 per WHWK's latest filing, from -$23.3 million in the prior quarter.
- Across five years, EBITDA topped out at $73.0 million in Q1 2025 and bottomed at -$52.6 million in Q2 2025.
- The 5-year median for EBITDA is -$16.3 million (2023), against an average of -$13.7 million.
- The widest annual swing landed in 2022, when EBITDA slumped 371.46%; it then surged 498.39% in 2025.
- Tracing WHWK's EBITDA over 5 years: stood at -$13.9 million in 2022, then declined by 16.49% to -$16.2 million in 2023, then slipped by 12.76% to -$18.3 million in 2024, then slipped by 27.19% to -$23.3 million in 2025, then rose by 4.04% to -$22.3 million in 2026.
- Per Business Quant, the three latest WHWK EBITDA figures stand at -$22.3 million (Q1 2026), -$23.3 million (Q4 2025), and -$17.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.63 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 661.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 201.19 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | -22.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.33 Mn |
| Dec 31, 2025 | -23.27 Mn |
| Sep 30, 2025 | -17.62 Mn |
| Jun 30, 2025 | -52.61 Mn |
| Mar 31, 2025 | 73.00 Mn |
| Dec 31, 2024 | -18.30 Mn |
| Sep 30, 2024 | -12.48 Mn |
| Jun 30, 2024 | -14.60 Mn |
| Mar 31, 2024 | -18.32 Mn |
| Dec 31, 2023 | -16.23 Mn |
| Sep 30, 2023 | -16.27 Mn |
| Jun 30, 2023 | -17.98 Mn |
| Mar 31, 2023 | -15.14 Mn |
| Dec 31, 2022 | -13.93 Mn |
| Sep 30, 2022 | -14.57 Mn |
| Jun 30, 2022 | -18.27 Mn |
| Mar 31, 2022 | -13.86 Mn |
| Dec 31, 2021 | -16.64 Mn |
| Sep 30, 2021 | -87.09 Mn |
| Jun 30, 2021 | -3.88 Mn |
| Mar 31, 2021 | -4.09 Mn |
| Dec 31, 2020 | 7.77 Mn |
| Sep 30, 2020 | -3.14 Mn |
| Jun 30, 2020 | 9.26 Mn |
| Mar 31, 2020 | -4.11 Mn |
| Dec 31, 2019 | -4.66 Mn |
| Sep 30, 2019 | -4.97 Mn |
| Jun 30, 2019 | -5.98 Mn |
| Mar 31, 2019 | -8.84 Mn |
| Dec 31, 2018 | -8.87 Mn |
| Sep 30, 2018 | 11.20 Mn |
| Jun 30, 2018 | -6.04 Mn |
| Mar 31, 2018 | -7.48 Mn |
| Dec 31, 2017 | -6.29 Mn |
| Sep 30, 2017 | -4.76 Mn |
| Jun 30, 2017 | -5.58 Mn |
| Mar 31, 2017 | -4.76 Mn |
| Dec 31, 2016 | -3.31 Mn |
| Sep 30, 2016 | -4.75 Mn |
| Jun 30, 2016 | -4.38 Mn |
| Mar 31, 2016 | -4.21 Mn |
| Dec 31, 2015 | -9,613.00 |
| Sep 30, 2015 | -4,328.00 |
| Jun 30, 2015 | -5,103.00 |
| Mar 31, 2015 | -3,962.00 |
| Dec 31, 2014 | -9,762.00 |
| Sep 30, 2014 | -4,765.00 |
| Jun 30, 2014 | -5,307.00 |
| Mar 31, 2014 | -4,138.00 |
| Dec 31, 2013 | -8,087.00 |
| Sep 30, 2013 | -4,475.00 |
| Jun 30, 2013 | -5,456.00 |
| Mar 31, 2013 | -4,806.00 |
| Dec 31, 2012 | -8,376.00 |
| Sep 30, 2012 | -4,753.00 |
| Jun 30, 2012 | -5,031.00 |
| Mar 31, 2012 | -4,231.00 |
| Dec 31, 2011 | -8,026.00 |
| Sep 30, 2011 | -5,430.00 |
| Jun 30, 2011 | -5,862.00 |
| Mar 31, 2011 | -4,266.00 |
| Dec 31, 2010 | -7,214.00 |
| Sep 30, 2010 | -4,238.00 |